Author:
Keicho Naoto,Hijikata Minako
Reference74 articles.
1. Akai S, Okayama H, Shimura S et al (1992) Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan. Am Rev Respir Dis 146:781–783
2. Albert RK, Connett J, Bailey WC et al (2011) Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365:689–698
3. Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EH, Koppers RJ, van der Werf TS, Boersma WG (2013) Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 309(12):1251–1259
4. Azuma A, Keicho N, Furukawa H et al (2001) Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin. Sarcoidosis Vasc Diffuse Lung Dis 18:312–313
5. Bakker PIW, McVean G, Sabeti PC et al (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38:1166–1172